Aptevo Therapeutics (APVO) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Aptevo Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $20K and 0 sold $0 of APVO stock on the open market.
Get emailed when insiders cluster-buy stocks like APVO
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
APVO insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $20K | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Aptevo Therapeutics Inc. insider reported open-market purchases totaling $20K, while 0 insiders reported sales totaling $0.
APVO earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 14, 2026 | -14.6% | None | -17.4%S&P -0.7% | -38.8% |
| May 13, 2026 | -1.8% | None | -0.7%S&P +1.4% | -0.3% |
| Mar 26, 2026 | -14.9% | None | -3.5%S&P -3.5% | +14.1% |
| Nov 6, 2025 | -8.9% | None | +2.8%S&P -1.0% | -8.2% |
| Aug 11, 2025 | -29.6% | None | -8.8%S&P +0.9% | -27.2% |
| May 15, 2025 | -41.7% | None | -3.0%S&P +1.1% | -31.4% |
| Apr 28, 2025 | -31.2% | None | -16.1%S&P +0.7% | -58.5% |
| Feb 14, 2025 | -15.5% | None | -4.1%S&P +0.3% | -29.2% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 12SEC | Grady Grant IIIDirector | Buy | 13,51313,514 held (+1351300%) | $1.49 | $20K | +20.1% | — |
Insiders at Aptevo Therapeutics Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Grady Grant IIIDirector | $20K | — | Nov 12, 2025 | — |
APVO stock: common questions
Are Aptevo Therapeutics Inc. insiders buying APVO stock?
In the past 12 months, 1 insiders reported open-market purchases of APVO worth $20K. The latest was Director Grady Grant III bought $20K of APVO at $1.49 — first open-market purchase in our records; raises the stake by 1351300%.
Are Aptevo Therapeutics Inc. insiders selling APVO stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is APVO's 52-week range?
Over the past year APVO has traded between $1.71 and $31.68. It last closed at $1.79 on Oct 9, 2026.